Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haihang Group is a China-based chemical manufacturing and trading group focused on fine chemicals, cosmetic materials, and pharmaceutical intermediates rather than on therapeutics development. Public company materials describe the group as comprising Haihang Industry together with affiliated entities such as Zhonglan Industry and, in some sources, METISARC or Xiaomifeng Supply Chain. The business appears to integrate R&D, production, and sales of industrial and specialty chemical products for global customers. While the group participates in pharmaceutical supply chains through intermediates and related materials, there is no clear evidence that it operates as a biotech or drug-development company with a clinical pipeline. It is best categorized as a commercial specialty chemicals business with some exposure to healthcare-related raw materials and intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haihang Group.